These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3538548)

  • 1. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplantation; 1986 Dec; 42(6):608-13. PubMed ID: 3538548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody.
    Tellis VA; Matas AJ; Senitzer D; Louis P; Glicklich D; Soberman R; Veith FJ
    Transplantation; 1989 Jan; 47(1):127-9. PubMed ID: 2643222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.
    Taylor CJ; Chapman JR; Ting A; Morris PJ
    Transplantation; 1989 Dec; 48(6):953-8. PubMed ID: 2595783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
    Bryan CF; Martinez J; Muruve N; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Harrell KM; Helling TS; Luger AM
    Clin Transplant; 2001; 15 Suppl 6():28-35. PubMed ID: 11903383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
    Tafulo S; Osório E; Mendes C; Liwski R
    Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft.
    Taylor CJ; Chapman JR; Fuggle SV; Ting A; Morris PJ
    Tissue Antigens; 1987 Sep; 30(3):104-12. PubMed ID: 3321555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossmatching with B and T cells and flow cytometry.
    Iwaki Y; Lau M; Cook DJ; Takemoto S; Terasaki PI
    Clin Transpl; 1986; ():277-84. PubMed ID: 3154417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not.
    Roelen DL; van Bree J; Witvliet MD; Habraken I; van Beelen E; van't Sant PH; de Waal LP; van Rood JJ; Claas FH
    Transplantation; 1994 May; 57(9):1388-92. PubMed ID: 8184480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs.
    Juhl D; Marget M; Hallensleben M; Görg S; Ziemann M
    Transpl Immunol; 2017 Mar; 41():17-21. PubMed ID: 28088367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions and clinical significance of IgM and autoantibodies in highly sensitized renal allograft recipients.
    Vaidya S; Ruth J
    Transplantation; 1989 Jun; 47(6):956-8. PubMed ID: 2660358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
    Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
    Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
    Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
    Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific B and T lymphocyte antibodies and kidney graft survival.
    Jeannet M; Benzonana G; Arni I
    Transplantation; 1981 Mar; 31(3):160-3. PubMed ID: 7015609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.